Clinical syndromes and treatment location predict utility of carbapenem sparing therapies in ceftriaxone-non-susceptible Escherichia coli bloodstream infection

Ouli Xie, Kathryn Cisera, Lucy Taylor, Carly Hughes, Benjamin Rogers

Centre for Inflammatory Disease Monash Health

Research output: Contribution to journal › Article › Research › peer-review

5 Citations (Scopus)

1 results

Filter

Curtailed

Ceftolozane/Tazobactam as a carbapenem sparing strategy: Insights from patient level data.
Rogers, B.
1/01/19 → 9/12/19
Project: Research